文献速递肾癌与肾肿瘤

肝病患者肾切除术的围手术期结局:对肝移植候选者的意义

Perioperative Nephrectomy Outcomes for Patients with Liver Disease: Implications for Liver Transplant Candidates.
PubMed 文献 · Urology · 2022-11-18

基于2016—2019年全国再入院数据库的回顾性研究,评估183362例非急诊肾切除术成人中无慢性肝病、慢性肝病与失代偿期肝硬化三组的围手术期结局。失代偿期肝硬化组死亡率7%,高于慢性肝病组0.4%与无慢性肝病组0.3%(P<.001),且并发症、再入院、非居家出院、住院时长和费用均更高。作者认为对这些患者可考虑替代管理策略。

要点

  • 失代偿期肝硬化患者肾切除术后死亡率7%,高于慢性肝病0.4%和无慢性肝病0.3%(P<.001)。
  • 失代偿期肝硬化与更高死亡率(OR 8.29)、术后需输血出血(OR 5.55)、非居家出院(OR 5.12)和再入院(OR 1.79)相关。
  • 失代偿期肝硬化组住院时长和费用最高,作者认为可考虑替代管理策略。

核心结论

  • 失代偿期肝硬化患者行肾切除术的并发症、死亡率、再入院率、非居家出院、住院时长和费用均增加。
  • 作者认为对这些患者可考虑替代管理策略。

研究设计与样本

  • 回顾性研究,使用2016—2019年全国再入院数据库,纳入因非急诊指征行肾切除术的成人。
  • 共评估183362例患者,分为无慢性肝病、慢性肝病和失代偿期肝硬化3组。
  • 采用混合回归模型评估慢性肝病和失代偿期肝硬化与结局的关联。

主要发现

  • 失代偿期肝硬化组死亡率为7%,慢性肝病组为0.4%,无慢性肝病组为0.3%(P<.001)。
  • 与无慢性肝病相比,失代偿期肝硬化与更高死亡率相关(OR 8.29,95%CI 4.07-16.88)。
  • 与无慢性肝病相比,失代偿期肝硬化与术后需输血出血相关(OR 5.55,95%CI 3.72-8.26)。
  • 与无慢性肝病相比,失代偿期肝硬化与非居家出院相关(OR 5.12,95%CI 3.16-8.30)。
  • 与无慢性肝病相比,失代偿期肝硬化与再入院相关(OR 1.79,95%CI 1.09-2.94)。

临床怎么用

  • 作者认为对失代偿期肝硬化患者行肾切除术可考虑替代管理策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To improve the management of cirrhotic patients diagnosed with new renal masses, we used a nationally representative cohort to assess the perioperative outcomes of nephrectomy in the setting of liver disease. The incidences of liver disease and renal masses are both rising in the US. Delaying liver transplantation to address other health concerns may have life changing consequences in these patients, thus these results help to guide treatment decisions at this critical junction in care. METHODS: A retrospective study of the 2016-2019 Nationwide Readmissions Database was performed in adults undergoing nephrectomy for non-emergent indications. Outcomes were compared between 3 cohorts: no chronic liver disease (no CLD), chronic liver disease (CLD), and decompensated cirrhosis (DC). Mixed regression models were used to evaluate the association between CLD and DC with outcomes of interest including morbidity, mortality, readmission rates, non-home discharges, length of stay, and costs. RESULTS: A total of 183,362 patients were evaluated. The mortality rate in the DC cohort (7%) was higher than with CLD (0.4%) and no CLD (0.3%), (P <.001). DC was associated with higher mortality (OR 8.29, 95% CI 4.07 - 16.88), postoperative bleeding requiring transfusion (OR 5.55, 95% CI 3.72 - 8.26), non-home discharge (OR 5.12, 95% CI 3.16 - 8.30) and readmission (OR 1.79, 95% CI 1.09 - 2.94) compared to no CLD. The DC cohort had the greatest length of stay and costs. CONCLUSION: Patients undergoing nephrectomy with DC have increased morbidity, mortality, readmission rates, non-home discharges, LOS and costs. Alternative management strategies may be considered in these patients.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Muraki P, Lee C, Patel N, et al. Perioperative Nephrectomy Outcomes for Patients with Liver Disease: Implications for Liver Transplant Candidates. Urology. 2022. PMID: 36403677. doi:10.1016/j.urology.2022.10.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。